SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

rheumatology

Is Rheumatoid Arthritis an Autoimmune Disease?

Yes — rheumatoid arthritis is an autoimmune disease. The immune system mistakenly attacks the synovial lining of the joints, causing inflammation that damages cartilage and bone if untreated. Unlike osteoarthritis, which results from mechanical wear, RA is driven by an immune process that can begin at any age.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

What makes rheumatoid arthritis an autoimmune disease?

In RA, the immune system produces antibodies and activates inflammatory cells (T cells, B cells, and macrophages) that target the synovium — the thin tissue lining the inside of joints. This triggers persistent inflammation, causing the synovial lining to thicken and produce excess fluid. Over time, the inflamed tissue (called pannus) can erode cartilage and bone, leading to joint damage and deformity 1.

Two autoantibodies are particularly associated with RA: - Rheumatoid factor (RF): Found in roughly two-thirds of people with RA, though also present in other conditions. - Anti-citrullinated protein antibodies (anti-CCP): More specific for RA and can appear years before symptoms develop 1.

The presence of these antibodies and the pattern of joint inflammation is what separates RA from ordinary wear-and-tear arthritis 3.

How is rheumatoid arthritis different from osteoarthritis?

This is one of the most common questions after receiving an arthritis diagnosis:

| | Rheumatoid arthritis | Osteoarthritis | |---|---|---| | Cause | Autoimmune inflammation | Cartilage wear and degeneration | | Age of onset | Any age, peaks 30–60 | Usually after 50 | | Joint pattern | Symmetric, small joints of hands and feet | Weight-bearing joints, fingertips | | Morning stiffness | Prolonged (more than 45 minutes) | Brief (usually under 30 minutes) | | Systemic symptoms | Fatigue, fever, weight loss possible | Typically joint-limited | | Blood markers | RF, anti-CCP, elevated ESR/CRP | Usually normal |

RA is a systemic disease — it can affect the lungs, heart, eyes, blood vessels, and skin in addition to joints 1.

What triggers the autoimmune attack in RA?

The exact cause of RA is not fully understood, but it involves a combination of genetic susceptibility and environmental triggers 3. Certain immune system genes (HLA-DR4 in particular) are associated with higher risk. Environmental factors that have been studied include:

  • Cigarette smoking: The strongest modifiable risk factor — smoking increases the risk of developing RA and is associated with more severe disease 1.
  • Periodontal (gum) disease: The bacteria involved may trigger the citrullination process that generates anti-CCP antibodies.
  • Microbiome changes: Alterations in gut or oral bacteria are an active research area.
  • Hormonal factors: RA is more common in women, and flares can occur around pregnancy and the postpartum period.

RA typically arises when genetic susceptibility meets an environmental trigger, shifting the immune system toward chronic self-directed inflammation.

How is rheumatoid arthritis treated?

Because RA is an immune-driven disease, treatment targets the immune process — not just the symptoms. The 2021 American College of Rheumatology guideline recommends a treat-to-target approach: setting measurable goals for disease activity and adjusting therapy until those goals are met 2. The 2022 EULAR update reinforces the same framework 4.

Disease-modifying antirheumatic drugs (DMARDs) are the foundation of RA treatment: - Methotrexate remains the most commonly used initial DMARD — it is taken weekly and works over several weeks to months. - Hydroxychloroquine, sulfasalazine, and leflunomide are other conventional options, often used in combination. - Biologic DMARDs (such as TNF inhibitors, IL-6 inhibitors, and JAK inhibitors) are added when conventional DMARDs are insufficient 2.

NSAIDs and low-dose corticosteroids can reduce symptoms in the short term while DMARDs take effect, but they are not substitutes for disease-modifying treatment. Early, aggressive treatment is associated with better long-term outcomes — including preservation of joint function and prevention of structural damage.

Who treats rheumatoid arthritis?

A rheumatologist is the specialist who diagnoses and manages RA. Because this is an autoimmune disease requiring immunosuppressive therapy and careful monitoring, specialist care is important from early in the disease. Your Gale clinician can help you understand whether your symptoms warrant rheumatology evaluation and coordinate that referral promptly.

Common questions

Can rheumatoid arthritis go away on its own?

RA is typically a chronic disease that does not resolve without treatment. However, with appropriate treatment many people achieve low disease activity or remission — periods where symptoms are minimal or absent. Remission is a realistic goal with modern therapy.

Is RA hereditary?

There is a genetic component, but RA is not directly inherited in a simple pattern. First-degree relatives of someone with RA have a modestly increased risk, but the majority of people with RA have no family history of it. Genes account for roughly half the risk; the rest comes from environmental factors.

Can smoking really cause rheumatoid arthritis?

Smoking is the most well-established modifiable risk factor for RA. In people who are genetically susceptible, smoking can trigger the production of anti-CCP antibodies — potentially years before any joint symptoms appear. Quitting smoking reduces disease activity and improves response to treatment in people who already have RA.

Does RA affect only joints?

No. RA is a systemic disease. It can cause inflammation in the lungs (interstitial lung disease), the lining around the heart (pericarditis), the eyes (scleritis), and blood vessels. Fatigue is a very common and significant symptom. Long-standing, poorly controlled RA increases cardiovascular risk.

What is the difference between RA and seronegative RA?

Seronegative RA refers to RA in which the rheumatoid factor and anti-CCP antibodies are negative. The joint involvement pattern and clinical picture are similar; diagnosis relies more heavily on clinical and imaging findings. About one-third of people with RA are seronegative.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Signs that need prompt evaluation

  • —Shortness of breath or chest pain in a person with known RA (possible lung or heart involvement)
  • —Sudden eye pain or redness in a person with RA (possible scleritis)
  • —Rapidly worsening joint pain with fever (possible infection, particularly if on immunosuppressive therapy)
  • —Neurological symptoms such as neck pain with arm tingling in a person with long-standing RA (cervical spine involvement)

Chest pain, severe shortness of breath, or sudden neurological symptoms warrant emergency evaluation — call 911 or go to the nearest ER.

This article provides general educational information about rheumatoid arthritis. It does not constitute a diagnosis or personal treatment recommendation. RA diagnosis and management require evaluation by a rheumatologist.

References

  1. 1.McInnes IB, Schett G (2011). The pathogenesis of rheumatoid arthritis. N Engl J Med. doi:10.1056/NEJMra1004965 ✓Autoimmune mechanism of RA — synovial inflammation, autoantibodies (RF and anti-CCP), T/B cell and macrophage involvement, smoking as environmental trigger; systemic extra-articular involvement
  2. 2.Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021). 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis & Rheumatology. doi:10.1002/art.41752 ✓Treat-to-target approach; DMARD hierarchy (methotrexate, biologics, JAK inhibitors); early aggressive treatment for joint preservation
  3. 3.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024). Rheumatoid Arthritis Symptoms, Causes, & Risk Factors. NIAMS Health Topics. link ✓RA as a chronic autoimmune disease; symmetric joint pattern; risk factors including genetics, smoking, gum disease
  4. 4.Smolen JS, Landewé RBM, Bergstra SA, et al. (2023). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases. doi:10.1136/ard-2022-223356 ✓Treat-to-target framework; DMARD sequencing (conventional synthetic, biologic, targeted synthetic) in RA management; methotrexate as anchor DMARD

4 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.